HomeCompareCVALF vs VICI

CVALF vs VICI: Dividend Comparison 2026

CVALF yields 8.37% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $954.0K in total portfolio value· pulled ahead in Year 2
10 years
CVALF
CVALF
● Live price
8.37%
Share price
$1.27
Annual div
$0.11
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.8K
Annual income
$1,420.80
Full CVALF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — CVALF vs VICI

📍 VICI pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVALFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVALF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CVALF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVALF
Annual income on $10K today (after 15% tax)
$711.52/yr
After 10yr DRIP, annual income (after tax)
$1,207.68/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, VICI beats the other by $528,564.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVALF + VICI for your $10,000?

CVALF: 50%VICI: 50%
100% VICI50/50100% CVALF
Portfolio after 10yr
$511.8K
Annual income
$312,341.06/yr
Blended yield
61.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

CVALF
No analyst data
Altman Z
5.0
Piotroski
4/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVALF buys
0
VICI buys
0
No recent congressional trades found for CVALF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVALFVICI
Forward yield8.37%6.57%
Annual dividend / share$0.11$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$34.8K$988.8K
Annual income after 10y$1,420.80$623,261.32
Total dividends collected$11.3K$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CVALF vs VICI ($10,000, DRIP)

YearCVALF PortfolioCVALF Income/yrVICI PortfolioVICI Income/yrGap
1$11,537$837.09$11,368$948.43+$169.00CVALF
2← crossover$13,247$902.57$13,339$1,493.16$92.00VICI
3$15,143$968.57$16,326$2,426.21$1.2KVICI
4$17,238$1,034.75$21,123$4,112.15$3.9KVICI
5$19,545$1,100.83$29,379$7,368.23$9.8KVICI
6$22,080$1,166.53$44,804$14,191.64$22.7KVICI
7$24,857$1,231.60$76,658$29,972.12$51.8KVICI
8$27,893$1,295.80$150,894$71,015.81$123.0KVICI
9$31,205$1,358.93$350,814$193,582.47$319.6KVICI
10$34,810$1,420.80$988,809$623,261.32$954.0KVICI

CVALF vs VICI: Complete Analysis 2026

CVALFStock

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. Its products include wound care dressings; surgical and peri-operative products; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.

Full CVALF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this CVALF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVALF vs SCHDCVALF vs JEPICVALF vs OCVALF vs KOCVALF vs MAINCVALF vs NNNCVALF vs EPRTCVALF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.